High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC

Detalles Bibliográficos
Autores principales: Jin, Zining, Zhang, Qingfu, Wang, Chunyu, Wang, Shengli, Lin, Lin, Zou, Renlong, Sun, Ge, Zeng, Kai, Zhou, Baosheng, Tong, Yuxin, Chen, Bo, Zhao, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827805/
https://www.ncbi.nlm.nih.gov/pubmed/35838199
http://dx.doi.org/10.3724/abbs.2022083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827805/
https://www.ncbi.nlm.nih.gov/pubmed/35838199
http://dx.doi.org/10.3724/abbs.2022083

Ejemplares similares